Related Experiment Videos
Androgen receptor and prostate cancer: molecular aspects and gene expression profiling
Anette Sommer1, Bernard Haendler
1Schering AG, Research Laboratories, Müllerstrasse 178, 13342 Berlin, Germany.
Abstract:
Prostate cancer represents a major health problem in the aging population of Western countries. Androgen ablation is one of the preferred treatments for this disease; unfortunately, relapse is often observed, and no therapeutic agent is available at this stage of the disease. Although numerous studies indicate that the androgen receptor (AR) remains largely involved at the late stages of the disease, the molecular mechanisms responsible for the transition from an androgen-dependent to an androgen-independent state are still poorly understood. Newly discovered aspects of the mode of action of AR, such as cross-talk with other signaling pathways, post-translational modifications, interaction with co-factors and allosteric modulation by DNA response elements have helped to broaden our knowledge on how target gene transcription is regulated. In addition, the gene expression profiles recently determined on prostate-derived cell lines and on normal and diseased prostate tissues should help to decipher the mechanisms leading to uncontrolled growth and metastasis.
Insights
Prostate cancer relapse after androgen ablation is common. Understanding androgen receptor (AR) regulation is key to developing new treatments for advanced prostate cancer and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Prostate cancer is a significant health issue in aging populations.
- Androgen ablation is a primary treatment, but relapse is frequent, with no effective therapies for advanced stages.
- The molecular mechanisms driving the transition to androgen independence remain unclear, despite the androgen receptor's (AR) continued involvement.
Purpose of the Study:
- To elucidate the poorly understood molecular mechanisms behind the transition from androgen-dependent to androgen-independent prostate cancer.
- To explore the role of androgen receptor (AR) regulation in advanced prostate cancer.
- To identify potential therapeutic targets for treatment-resistant prostate cancer.
Main Methods:
- Review of newly discovered aspects of androgen receptor (AR) action, including signaling pathway cross-talk, post-translational modifications, co-factor interactions, and allosteric modulation.
- Analysis of gene expression profiles from prostate cell lines and tissues.
- Investigation of mechanisms regulating target gene transcription.
Main Results:
- Emerging insights into AR's complex mode of action, including its interactions with other pathways and regulatory elements.
- Gene expression profiling provides data to decipher mechanisms of uncontrolled growth and metastasis.
- The androgen receptor (AR) remains critical in late-stage disease, but its precise role in resistance is still being uncovered.
Conclusions:
- Further research into AR regulation and gene expression is crucial for understanding and treating advanced prostate cancer.
- New therapeutic strategies may emerge from a deeper understanding of AR's complex role in treatment resistance.
- Deciphering AR's regulatory mechanisms and gene expression profiles is essential for combating prostate cancer metastasis.